Tuberous sclerosis complex: A clinical diagnosis in Ethiopian patients
Open Access
- 9 February 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (6) , e37135
Abstract
Rationale: Tuberous sclerosis complex (TSC) is a rare autosomal dominant inherited disorder characterized by the development of nonmalignant tissue growths (hamartomas) in various organ systems, often located in the brain, skin, heart, lung and kidneys. The delayed diagnosis could be attributed to low expectation or exposure of physicians to this rare disease. High index of clinical suspicion is required for early diagnosis of rare diseases to prevent adverse outcomes. Patient concerns: The first patient, a 27-year-old man, presented with intermittent left flank pain and hematuria of 5 months duration. On examination of the skin and oral cavity, he had fibrous cephalic plaque, facial angiofibromas, ungual fibromas, confetti skin lesions, and intraoral fibromas. A CT scan of the chest, abdomen, and brain displayed cystic lung parenchymal changes and multifocal micronodular pneumocyte hyperplasia, angiomyolipomas in both kidneys, and multiple calcified subependymal nodules (SEN), respectively. The second patient, a 28-year-old woman, presented with a seizure disorder in the last 1 year, and papular and nodular lesions over her face since childhood. On examination of the skin and oral cavity, she had hypomelanotic macules, facial angiofibromas, shagreen patches, ungual fibromas, intraoral fibromas, and dental enamel pits. Diagnoses: Definitive diagnosis of TSC was made in both patients using the “2012 tuberous sclerosis complex diagnostic criteria consensus statement.” Interventions: The first patient was seen by various medical discipline teams, and suggested close follow-up in the “chronic illness clinic” of the hospital. The second patient was scheduled in dermatology clinic for electrocautery for disfiguring facial nodules. Outcome: Both patients were scheduled for close follow-up in the hospital. Lessons: The patients described had TSC using “clinical diagnostic criteria.” Under the clinical diagnostic criteria of TSC, 4 of 11 major criteria and 3 of 7 minor criteria are skin features. Hence, awareness on skin features as clinical markers to suspect TSC should be emphasized in resource-limited countries.Keywords
This publication has 13 references indexed in Scilit:
- Finding a cure for tuberous sclerosis complex: From genetics through to targeted drug therapies2019
- First descriptions of tuberous sclerosis by Desire-Magloire Bourneville (1840-1909)Neuropathology, 2018
- Tuberous sclerosis complex: Recent advances in manifestations and therapyInternational Journal of Urology, 2017
- Tuberous Sclerosis Complex: A ReviewPediatric Annals, 2017
- Tuberous sclerosis complex in the Western Cape, South Africa: The clinical presentation featuresSouth African Medical Journal, 2017
- Genetics of tuberous sclerosis complex: implications for clinical practiceThe Application of Clinical Genetics, 2016
- Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapyNeuropsychiatric Disease and Treatment, 2016
- Tuberous sclerosis complexNature Reviews Disease Primers, 2016
- Clinical management of tuberous sclerosis complex over the lifetime of a patientPediatric Health, Medicine and Therapeutics, 2015
- Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus ConferencePediatric Neurology, 2013